SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-089171
Filing Date
2020-07-31
Accepted
2020-07-31 17:21:18
Documents
4
Period of Report
2020-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2025143d6_8k.htm 8-K 25669
2 EXHIBIT 1.1 tm2025143d6_ex1-1.htm EX-1.1 291375
3 EXHIBIT 5.1 tm2025143d6_ex5-1.htm EX-5.1 11107
4 GRAPHIC tm2025143d6_ex5-1img001.jpg GRAPHIC 3724
  Complete submission text file 0001104659-20-089171.txt   334543
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 201066955
SIC: 2834 Pharmaceutical Preparations